Drug Profile
Tissue factor
Latest Information Update: 17 Sep 2021
Price :
$50
*
At a glance
- Originator Genentech
- Class Antihaemorrhagics; Blood coagulation factors; Coagulants
- Mechanism of Action Blood coagulation factor stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Haemophilia
Most Recent Events
- 03 Jul 2001 Discontinued-Preclinical for Haemophilia in USA (Unknown route)
- 14 Dec 1994 Preclinical development for Haemophilia in USA (Unknown route)